Ace Inhibitors Current Events | Ace Inhibitors News | 2
|
| Page
2 of
19 |
379 Results |
|
|
|
Sort By:
Page Views | Date |
Blood pressure enzyme can have tumor-sensing role
By increasing production of a blood pressure-regulating enzyme in mice, researchers have found they can enhance the mouse immune system's ability to sense tumor growth. view more (2008-04-08)
Amias® (candesartan cilexetil), an antihypertensive drug, now shows clear benefits in symptomatic heart failure
Amias® (candesartan cilexetil), an antihypertensive drug, now shows clear benefits in symptomatic heart failure CHARM Study Programme demonstrates that Amias® saves lives and reduces hospitalisation in heart failure, irrespective of background therapy European Society of Cardiology, Vienna, 31st August 2003 - Exciting results from the... view more... (2003-08-31)
Blood pressure drug shows potential as lung cancer treatment
A hormone that is important in the control of blood pressure also shrinks lung cancer tumors in mice, suggesting a new way to prevent or treat the deadly cancer, according to scientists at Wake Forest University School of Medicine. view more (2007-03-15)
Avoiding heart failure after cancer drugs - new hope for early diagnosis, treatment and prevention of cardiotoxicity
New hope that heart failure - a potentially fatal side effect of some types of cancer drugs - can be diagnosed early and successfully treated or even prevented, is reported today (Thursday 2 May) in Annals of Oncology, journal of the European Society for Medical Oncology. A team from the University of Milan* has found evidence that elevated blood... view more... (2002-04-28)
Despite No Gender Difference in Adverse Drug Reactions, Women are Treated Less Frequently than Men with Statins, Aspirin and Beta- Blockers
Women and men experience a similar prevalence of adverse drug reactions in the treatment of coronary artery disease; however, women are significantly less likely than their male counterparts to be treated with statins, aspirin, and beta-blockers according to a new study by researchers at Rush University Medical Center. view more (2008-03-05)
Low-dose aspirin reduces cardiovascular events
Taking low-dose aspirin daily reduces the risk of heart attack and stroke, as well as the risk of dying, among patients who previously have had a heart attack or stroke but whose cardiovascular disease has stabilized. view more (2006-11-16)
'Polypill' improves survival rates for heart disease sufferers, says University study
A 'polypill' made up of a combination of drugs could extend the lives of thousands of patients with coronary heart disease, say researchers at The University of Nottingham. view more (2005-05-09)
Genetic faults in heart enzyme increase risk of heart attack and stroke
Genetic faults, which produce an excess of a powerful enzyme, increase the risk of coronary artery disease and consequently, a heart attack, shows research in Heart. But the faulty genes do not speed up artery narrowing, the cause of acute coronary artery disease, the research shows. Over 850 men with stable coronary artery disease in their 50s... view more... (2001-03-13)
Heart failure patients do better when treated according to guidelines, but too many doctors still fail to prescribe the best treatments
Heart failure patients who are treated in accordance with established European guidelines do better than patients who are not, yet many doctors are still not adhering to the guidelines, according to pioneering research published today (Tuesday 3 May) in Europe's leading cardiology journal, the European Heart Journal. view more (2005-04-28)
Regular use of selective COX-2 inhibitors decreases risk of breast cancer
Regular use of selective COX-2 inhibitors significantly reduces the risk of breast cancer. view more (2006-01-30)
Certain blood pressure-lowering drugs reduce diabetes risk in Hispanic patients
The combination of drugs traditionally used to control blood pressure might not be ideal for Hispanic patients, University of Florida researchers warn. view more (2006-05-23)
Aromatase inhibitors: A treatment of choice for advanced breast cancer patients
Aromatase inhibitors improve the survival of advanced breast cancer patients compared to standard hormone therapies like tamoxifen. view more (2006-09-20)
New arthritis drugs less likely to cause side effects
A new group of arthritis drugs recommended by NICE for patients at risk of gastrointestinal complications may be safer than traditional drugs, research in this week's BMJ suggests. Claims that the drugs, known as selective COX2 inhibitors, caused fewer gastrointestinal problems than traditional arthritis drugs led to an increase in their use, but... view more... (2002-09-18)
High blood pressure and kidney disease increase risk for heart disease and stroke in older Americans
Older Americans with high blood pressure and moderate to severe chronic kidney disease have a greater chance of developing heart disease than people with normal kidney function. view more (2006-02-07)
DOES TREATING HIGH BLOOD PRESSURE SAVE LIVES? (P1305)
Findings of a meta-analysis published in this week's issue of The Lancet emphasise that blood pressure control is important and that on average, all antihypertensive drugs have similar long-term efficacy and safety. One of the most common causes of death in the developed world is cardiovascular disease (heart attacks and strokes). Measures to... view more... (2001-10-17)
Drugs may not delay onset of dementia; and more
Researchers have examined the evidence in favour of giving people considered to be close to developing dementia the drugs that are most commonly used to treat the condition itself. view more (2007-11-27)
Combination therapy reduces tumor resistance to radiation
Radiation is used to treat a variety of tumors and the response of tumors to radiation is dependent on endothelial cell death, which in turn limits oxygen delivery to the tumor, causing hypoxia and tumor cell death. view more (2007-06-08)
Scleroderma Outlook Improves as Survival Increases
Individuals with scleroderma are living significantly longer today, compared with 30 years ago, and the physicians who treat this rare disease of connective tissue hope the newer drugs now on the market may extend lives even further. view more (2007-07-13)
Antiprotons 4 times more effective than protons for cell irradiation
A pioneering experiment at CERN with potential future application in cancer therapy has produced its first results. Started in 2003, ACE (Antiproton Cell Experiment) is the first investigation of the biological effects of antiprotons. view more (2006-11-01)
Experiments point to new treatments for PKD
A family of small molecules called CFTR inhibitors show promising effects in slowing the progression of polycystic kidney disease (PKD), the most common genetic disease of the kidneys, according to preliminary research reported in the July 2008 issue of the Journal of the American Society Nephrology. view more (2008-04-03)
|
|
| Page
2 of
19 |
379 Results |
|
|
|
Sort By:
Page Views | Date |
|
